| Literature DB >> 35582133 |
Du-Jiang Yang1, Hui-Min Lu2, Yong Liu1, Mao Li2, Wei-Ming Hu2, Zong-Guang Zhou3.
Abstract
BACKGROUND: The severity of acute pancreatitis in pregnancy (APIP) is correlated with higher risks of maternal and fetal death. AIM: To develop a nomogram that could predict moderately severe and severe acute pancreatitis in pregnancy (MSIP).Entities:
Keywords: Acute pancreatitis; Nomogram; Prediction model; Pregnancy; Random forest; Severity
Mesh:
Substances:
Year: 2022 PMID: 35582133 PMCID: PMC9048464 DOI: 10.3748/wjg.v28.i15.1588
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.374
Figure 1Flow chart of the study. APIP: Acute pancreatitis in pregnancy; MAIP: Mild acute pancreatitis in pregnancy; MSIP: Moderately severe and severe acute pancreatitis in pregnancy.
Demographics and clinical characteristics of acute pancreatitis patients in pregnancy
|
|
|
|
|
| Age | 27.61 ± 5.25 | 29.46 ± 5.57 | 0.032 |
| Etiology | 0.514 | ||
| Hypertriglyceridemia | 50 (36.8) | 24 (44.4) | |
| Gallstone | 45 (33.1) | 19 (35.2) | |
| Other | 41 (30.1) | 11 (20.4) | |
| Comorbidity | |||
| Hypertension | 0 (0.0) | 2 (3.7) | 0.080 |
| Diabetes | 8 (5.9) | 13 (24.1) | 0.001 |
| Fatty liver disease | 32 (23.5) | 16 (29.6) | 0.492 |
| Smoking | 3 (2.2) | 2 (3.7) | 0.937 |
| Drinking | 4 (2.9) | 1 (1.9) | 1.000 |
| Trimester of pregnancy on admission | |||
| Early (1–12 wk) | 9 (6.6) | 3(5.6) | |
| Mid (12–24 wk) | 31 (22.8) | 10(18.5) | |
| Late (24–40 wk) | 96 (70.6) | 41(75.9) | |
| Gestational weeks on admission | 28.04 ± 7.72 | 28.80 ± 6.64 | 0.520 |
| Onset to admission (days) | 1.59 ± 1.37 | 1.88 ± 1.65 | 0.220 |
| Blood infection | 0 (0.0) | 8 (14.8) | < 0.001 |
| LOS | 7.25 ± 4.27 | 11.88 ± 7.42 | < 0.001 |
| Fetal death | 3 (2.2) | 13(24.1) | < 0.001 |
| Maternal hospital mortality | 0 (0.0) | 1(2.9) | 0.284 |
| Hematocrit | 0.33 ± 0.05 | 0.32 ± 0.06 | 0.155 |
| Platelet | 164.42 ± 55.01 | 147.55 ± 65.17 | 0.072 |
| WBC | 12.59 ± 4.71 | 14.15 ± 4.15 | 0.035 |
| Neutrophils | 10.86 ± 4.40 | 12.49 ± 3.97 | 0.019 |
| Lymphocytes | 1.01 ± 0.40 | 0.88 ± 0.47 | 0.068 |
| Monocytes | 0.55 ± 0.23 | 0.48 ± 0.27 | 0.064 |
| Alanine aminotransferase | 50.94 ± 78.74 | 19.57 ± 37.40 | 0.006 |
| Albumin | 34.22 ± 3.70 | 29.36 ± 5.17 | < 0.001 |
| Creatinine | 42.57 ± 9.30 | 75.87 ± 100.15 | < 0.001 |
| Aspartate aminotransferase | 51.17 ± 67.61 | 35.07 ± 50.13 | 0.115 |
| Alkaline phosphatase | 113.56 ± 52.19 | 95.38 ± 36.87 | 0.020 |
| Creatine kinase | 36.20 ± 25.87 | 126.36 ± 213.49 | < 0.001 |
| LDH | 185.32 ± 66.39 | 346.93 ± 208.95 | < 0.001 |
| Triglyceride | 5.87 ± 6.72 | 12.57 ± 7.34 | < 0.001 |
| Cholesterol | 7.34 ± 5.63 | 12.80 ± 6.64 | < 0.001 |
| High density lipoprotein | 1.40 ± 0.48 | 1.16 ± 0.39 | 0.001 |
| Low density lipoprotein | 2.24 ± 1.23 | 1.94 ± 1.59 | 0.158 |
| Sodium | 135.62 ± 3.82 | 133.57 ± 5.43 | 0.004 |
| Potassium | 3.76 ± 0.34 | 3.83 ± 0.46 | 0.294 |
| Chlorine | 102.17 ± 4.46 | 102.44 ± 6.40 | 0.735 |
MAIP: Mild acute pancreatitis in pregnancy; MSIP: Moderately severe and severe acute pancreatitis in pregnancy; LOS: Length of hospital stay; WBC: White blood cell; LDH: Lactate dehydrogenase.
Demographic and clinical characteristics of patients in training group
|
|
|
| ||||
|
|
|
|
|
|
|
|
| Age | 27.16 ± 5.46 | 30.13 ± 6.09 | 0.007 | 28.70 ± 4.60 | 27.88 ± 3.79 | 0.528 |
| Etiology | 0.620 | 0.804 | ||||
| Hypertriglyceridemia | 32 (33.3) | 18 (47.4) | 18 (45.0) | 7 (43.8) | ||
| Gallstone | 36 (37.5) | 13 (34.2) | 9 (22.5) | 5 (31.2) | ||
| Other | 28 (29.2) | 7 (18.4) | 13 (32.5) | 4 (25.0) | ||
| Comorbidity | ||||||
| Hypertension | 0 (0.0) | 2 (5.3) | 0.079 | 0 (0.0) | 0 (0.0) | - |
| Diabetes | 6 (6.3) | 9 (23.7) | 0.012 | 2 (5.0) | 4 (25.0) | 0.049 |
| Fatty liver disease | 20 (20.8) | 11 (28.9) | 0.437 | 12 (30.0) | 5 (31.2) | 1.000 |
| Smoking | 1 (1.0) | 2 (5.3) | 0.400 | 2 (5.0) | 0 (0.0) | 0.909 |
| Drinking | 3 (3.1) | 1 (2.6) | 1.000 | 1 (2.5) | 0 (0.0) | 1.000 |
| Trimester of pregnancy on admission | ||||||
| Early (1–12 wk) | 6 (6.3) | 2 (5.3) | 3 (7.5) | 1 (6.3) | ||
| Mid (12–24 wk) | 22 (22.9) | 8 (21.1) | 9 (22.5) | 2 (12.5) | ||
| Late (24–40 wk) | 68 (70.8) | 28 (73.7) | 28 (70.0) | 13 (81.3) | ||
| Gestational weeks on admission | 27.53 ± 7.52 | 29.74 ± 6.34 | 0.113 | 29.25 ± 8.15 | 26.56 ± 7.01 | 0.252 |
| Onset to admission (d) | 1.63 ± 1.35 | 2.12 ± 1.87 | 0.090 | 1.50 ± 1.44 | 1.29 ± 0.63 | 0.586 |
| Blood infection | 0 (0.0) | 6 (15.8) | < 0.001 | 0 (0.0) | 2 (12.5) | 0.139 |
| LOS | 6.99 ± 4.43 | 23.11 ± 48.52 | < 0.001 | 7.90 ± 3.63 | 18.25 ± 12.96 | 0.001 |
| Fetal death | 1 (1.0) | 9 (23.7) | < 0.001 | 2 (5.0) | 4 (25.0) | 0.049 |
| Maternal hospital mortality | 0 (0.0) | 1 (2.6) | 0.284 | 0 (0.0) | 0 (0.0) | - |
| Hematocrit | 0.33 ± 0.05 | 0.32 ± 0.06 | 0.734 | 0.33 ± 0.05 | 0.30 ± 0.05 | 0.040 |
| Platelet | 169.57 ± 56.91 | 141.97 ± 61.66 | 0.015 | 152.07 ± 48.61 | 160.80 ± 73.24 | 0.604 |
| WBC | 12.89 ± 4.82 | 13.94 ± 4.10 | 0.239 | 11.87 ± 4.42 | 14.64 ± 4.37 | 0.038 |
| Neutrophils | 11.19 ± 4.52 | 12.34 ± 3.83 | 0.166 | 10.09 ± 4.06 | 12.85 ± 4.39 | 0.029 |
| Lymphocytes | 1.00 ± 0.38 | 0.91 ± 0.49 | 0.246 | 1.01 ± 0.44 | 0.81 ± 0.41 | 0.129 |
| Monocytes | 0.55 ± 0.23 | 0.48 ± 0.29 | 0.147 | 0.56 ± 0.25 | 0.47 ± 0.22 | 0.249 |
| Alanine aminotransferase | 55.20 ± 82.18 | 22.91 ± 44.14 | 0.024 | 40.73 ± 69.69 | 11.62 ± 6.40 | 0.103 |
| Albumin | 34.44 ± 3.72 | 29.68 ± 5.49 | < 0.001 | 33.71 ± 3.62 | 28.62 ± 4.41 | < 0.001 |
| Creatinine | 42.90 ± 9.16 | 86.27 ± 117.45 | < 0.001 | 41.78 ± 9.69 | 51.17 ± 22.10 | 0.030 |
| Aspartate aminotransferase | 54.45 ± 69.25 | 40.67 ± 58.67 | 0.281 | 43.33 ± 63.66 | 21.77 ± 10.97 | 0.186 |
| Alkaline phosphatase | 114.05 ± 51.61 | 100.65 ± 37.29 | 0.148 | 112.39 ± 54.23 | 82.86 ± 33.70 | 0.048 |
| creatine kinase | 36.46 ± 26.55 | 129.89 ± 242.89 | < 0.001 | 35.58 ± 24.47 | 117.98 ± 124.10 | < 0.001 |
| LDH | 183.85 ± 63.85 | 356.97 ± 234.19 | < 0.001 | 188.86 ± 72.86 | 323.09 ± 134.59 | < 0.001 |
| Triglyceride | 5.44 ± 6.86 | 12.62 ± 8.01 | < 0.001 | 6.91 ± 6.33 | 12.46 ± 5.66 | 0.004 |
| cholesterol | 6.79 ± 4.43 | 12.19 ± 6.18 | < 0.001 | 8.68 ± 7.70 | 14.24 ± 7.63 | 0.018 |
| High density lipoprotein | 1.42 ± 0.49 | 1.18 ± 0.39 | 0.007 | 1.34 ± 0.43 | 1.12 ± 0.40 | 0.078 |
| Low density lipoprotein | 2.27 ± 1.18 | 2.00 ± 1.58 | 0.282 | 2.17 ± 1.35 | 1.78 ± 1.67 | 0.364 |
| Sodium | 135.91 ± 3.19 | 133.94 ± 5.71 | 0.012 | 134.93 ± 5.01 | 132.68 ± 4.72 | 0.129 |
| Potassium | 3.76 ± 0.30 | 3.88 ± 0.47 | 0.075 | 3.78 ± 0.44 | 3.71 ± 0.45 | 0.588 |
| Chlorine | 102.63 ± 4.22 | 103.14 ± 6.80 | 0.597 | 101.06 ± 4.85 | 100.78 ± 5.14 | 0.849 |
MAIP: Mild acute pancreatitis in pregnancy; MSIP: Moderately severe and severe acute pancreatitis in pregnancy; LOS: Length of hospital stay; WBC: White blood cell; LDH: Lactate dehydrogenase.
Figure 2Selection of risk factors of moderately severe and severe acute pancreatitis in pregnancy using the least absolute shrinkage and selection operator logistic regression algorithm. Least absolute shrinkage and selection operator coefficient profiles of the 29 candidate variables. For the optimal lambda, 4 features with a non-0 coefficient were selected.
Figure 3Nomogram for predicting moderately severe and severe acute pancreatitis in pregnancy. Nomogram including four risk factors (lactate dehydrogenase, triglyceride, cholesterol, and albumin were identified as risk factors) to predict moderately severe and severe acute pancreatitis in pregnancy. LDH: Lactate dehydrogenase.
Figure 4Performance of the nomogram in moderately severe and severe acute pancreatitis in pregnancy prediction. A: Receiver operating characteristic curves in the training set; B: Receiver operating characteristic curves in test set; C: Calibration curves of training set; D: Calibration curves of the test set.
Receiver operating characteristic curves at the optimal cut-off point according to different models
|
|
|
|
|
| Training set | |||
| Logistic model | 0.865 | 0.868 | 0.771 |
| Random forest model | 1.000 | 1.000 | 1.000 |
| Validation set | |||
| Logistic model | 0.853 | 0.812 | 0.875 |
| Random forest model | 0.870 | 0.812 | 0.875 |
AUC: Area under the receiver operating characteristic curve.
Figure 5Development and assessment of the random forest algorithm in moderately severe and severe acute pancreatitis in pregnancy prediction. A: Relationship between out-of-bag error and number of trees. In total, 75 trees are selected to establish a random forest model; B: Feature importance; C: Receiver operating characteristic curves in the training set; D: Receiver operating characteristic curves in test set; E: Calibration curves of training set; F: Calibration curves of the test set.